• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SCN9A(Nav1.7)和 SCN10A(Nav1.8)突变啮齿动物模型的疼痛行为。

Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.

机构信息

Université de Strasbourg, CNRS, INSERM, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) Translational Medicine and Neurogenetics Department, Illkirch, France.

Université de Strasbourg, CNRS, INSERM, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) Translational Medicine and Neurogenetics Department, Illkirch, France.

出版信息

Neurosci Lett. 2021 May 14;753:135844. doi: 10.1016/j.neulet.2021.135844. Epub 2021 Mar 26.

DOI:10.1016/j.neulet.2021.135844
PMID:33775738
Abstract

The two voltage gated sodium channels Nav1.7 and Nav1.8 are expressed in the peripheral nervous system and involved in various pain conditions including inflammatory and neuropathic pain. Rodent models bearing deletions or mutations of the corresponding genes, Scn9a and Scn10a, were created in order to understand the role of these channels in the pathophysiological mechanism underlying pain symptoms. This review summarizes the pain behavior profiles reported in Scn9a and Scn10a rodent models. The complete loss-of-function or knockout (KO) of Scn9a or Scn10a and the conditional KO (cKO) of Scn9a in specific cell populations were shown to decrease sensitivity to various pain stimuli. The Possum mutant mice bearing a dominant hypermorphic mutation in Scn10a revealed higher sensitivity to noxious stimuli. Several gain-of-function mutations were identified in patients with painful small fiber neuropathy. Future knowledge obtained from preclinical models bearing these mutations will allow understanding how these mutations affect pain. In addition, the review gives perspectives for creating models that better mimic patients' pain symptoms in view to developing novel analgesic strategies.

摘要

电压门控钠离子通道 Nav1.7 和 Nav1.8 在外周神经系统中表达,并参与各种疼痛情况,包括炎症性疼痛和神经性疼痛。为了了解这些通道在疼痛症状的病理生理机制中的作用,创建了携带相应基因 Scn9a 和 Scn10a 缺失或突变的啮齿动物模型。本综述总结了 Scn9a 和 Scn10a 啮齿动物模型中报道的疼痛行为特征。Scn9a 或 Scn10a 的完全功能丧失或敲除 (KO) 以及 Scn9a 在特定细胞群中的条件性 KO (cKO) 显示出对各种疼痛刺激的敏感性降低。在 Scn10a 中携带显性超活性突变的 Possum 突变小鼠对有害刺激的敏感性更高。在患有痛性小纤维神经病的患者中发现了几种功能获得性突变。从携带这些突变的临床前模型中获得的未来知识将允许了解这些突变如何影响疼痛。此外,该综述为创建更好地模拟患者疼痛症状的模型提供了视角,以期开发新的镇痛策略。

相似文献

1
Pain behavior in SCN9A (Nav1.7) and SCN10A (Nav1.8) mutant rodent models.SCN9A(Nav1.7)和 SCN10A(Nav1.8)突变啮齿动物模型的疼痛行为。
Neurosci Lett. 2021 May 14;753:135844. doi: 10.1016/j.neulet.2021.135844. Epub 2021 Mar 26.
2
Yield of peripheral sodium channels gene screening in pure small fibre neuropathy.周围性钠通道基因突变筛查在单纯性小纤维神经病中的作用。
J Neurol Neurosurg Psychiatry. 2019 Mar;90(3):342-352. doi: 10.1136/jnnp-2018-319042. Epub 2018 Dec 15.
3
Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.拉科酰胺治疗功能获得性Nav1.7突变相关小纤维神经病患者的疗效、安全性及耐受性:一项随机对照试验的研究方案——LENSS研究
Trials. 2016 Jun 30;17(1):306. doi: 10.1186/s13063-016-1430-1.
4
[Pain and analgesia : Mutations of voltage-gated sodium channels].[疼痛与镇痛:电压门控钠通道的突变]
Schmerz. 2017 Feb;31(1):14-22. doi: 10.1007/s00482-016-0139-0.
5
Painful and painless channelopathies.痛觉和无痛觉通道病。
Lancet Neurol. 2014 Jun;13(6):587-99. doi: 10.1016/S1474-4422(14)70024-9. Epub 2014 May 6.
6
Influence of androgenic blockade with flutamide on pain behaviour and expression of the genes that encode the NaV1.7 and NaV1.8 voltage-dependent sodium channels in a rat model of postoperative pain.氟他胺的雄激素阻断作用对术后疼痛大鼠模型疼痛行为和编码 NaV1.7 和 NaV1.8 电压门控钠离子通道的基因表达的影响。
J Transl Med. 2019 Aug 27;17(1):287. doi: 10.1186/s12967-019-2031-z.
7
A gain-of-function voltage-gated sodium channel 1.8 mutation drives intense hyperexcitability of A- and C-fiber neurons.功能获得性电压门控钠通道1.8突变导致A纤维和C纤维神经元强烈的过度兴奋性。
Pain. 2014 May;155(5):896-905. doi: 10.1016/j.pain.2014.01.012. Epub 2014 Jan 18.
8
The G1662S NaV1.8 mutation in small fibre neuropathy: impaired inactivation underlying DRG neuron hyperexcitability.小纤维神经病中的 G1662S NaV1.8 突变:损害了背根神经节神经元过度兴奋的失活。
J Neurol Neurosurg Psychiatry. 2014 May;85(5):499-505. doi: 10.1136/jnnp-2013-306095. Epub 2013 Sep 4.
9
Small-fiber neuropathy Nav1.8 mutation shifts activation to hyperpolarized potentials and increases excitability of dorsal root ganglion neurons.小型纤维神经病 Nav1.8 突变将激活转移到超极化电位,并增加背根神经节神经元的兴奋性。
J Neurosci. 2013 Aug 28;33(35):14087-97. doi: 10.1523/JNEUROSCI.2710-13.2013.
10
Genetic Analysis of , , and in Familial Episodic Pain Syndrome (FEPS) in Japan and Proposal of Clinical Diagnostic Criteria.遗传性家族性发作性疼痛综合征(FEPS)中 、 、 的基因分析及临床诊断标准的建立。
Int J Mol Sci. 2024 Jun 21;25(13):6832. doi: 10.3390/ijms25136832.

引用本文的文献

1
Neuronal ion channel modulation by Drimys winteri compounds: Opening a new chemical space to neuropharmacology.南美盖桂皮化合物对神经元离子通道的调节作用:为神经药理学开辟新的化学空间。
Neural Regen Res. 2026 Apr 1;21(4):1373-1382. doi: 10.4103/NRR.NRR-D-24-01194. Epub 2025 Jun 19.
2
Pain in idiopathic scoliosis not associated with known genetic variants for pain.特发性脊柱侧凸中的疼痛与已知的疼痛相关基因变异无关。
Pain Rep. 2024 Dec 19;10(1):e1227. doi: 10.1097/PR9.0000000000001227. eCollection 2025 Feb.
3
[ Capsule alleviates cartilage degeneration in mice with knee osteoarthritis by modulating Nav1.7].
[胶囊通过调节Nav1.7减轻膝骨关节炎小鼠的软骨退变]
Nan Fang Yi Ke Da Xue Xue Bao. 2024 Nov 20;44(11):2074-2081. doi: 10.12122/j.issn.1673-4254.2024.11.03.
4
Frontiers in Acute Pain Management: Emerging Concepts in Pain Pathways and the Role of VX-548 as a Novel NaV1.8 Inhibitor: A Narrative Review.急性疼痛管理前沿:疼痛通路中的新兴概念和 VX-548 作为新型 Nav1.8 抑制剂的作用:一篇叙述性评论。
Curr Pain Headache Rep. 2024 Nov;28(11):1135-1143. doi: 10.1007/s11916-024-01295-7. Epub 2024 Jul 4.
5
The Use of Compounds Derived from in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders.在癫痫、疼痛病症以及神经精神和神经退行性疾病的治疗中使用来源于 的化合物。
Int J Mol Sci. 2024 May 25;25(11):5749. doi: 10.3390/ijms25115749.
6
Long noncoding RNA small nucleolar RNA host gene 5 facilitates neuropathic pain in spinal nerve injury by promoting SCN9A expression via CDK9.长链非编码RNA小核仁RNA宿主基因5通过CDK9促进SCN9A表达,从而加剧脊髓神经损伤后的神经性疼痛。
Hum Cell. 2024 Mar;37(2):451-464. doi: 10.1007/s13577-023-01019-w. Epub 2024 Jan 2.
7
Identification of founder and novel mutations that cause congenital insensitivity to pain (CIP) in palestinian patients.鉴定导致巴勒斯坦患者先天性无痛症(CIP)的创始突变和新突变。
BMC Med Genomics. 2023 May 30;16(1):120. doi: 10.1186/s12920-023-01544-5.
8
Na1.7 gain-of-function mutation I228M triggers age-dependent nociceptive insensitivity and C-LTMR dysregulation.Na1.7 获得性功能突变 I228M 触发年龄依赖性痛觉不敏感和 C-LTMR 失调。
Exp Neurol. 2023 Jun;364:114393. doi: 10.1016/j.expneurol.2023.114393. Epub 2023 Mar 30.
9
SCN9A variant in a family of mixed breed dogs with congenital insensitivity to pain.一个混血犬家族中存在 SCN9A 变异,该家族患有先天性痛觉缺失症。
J Vet Intern Med. 2023 Jan;37(1):230-235. doi: 10.1111/jvim.16610. Epub 2023 Jan 11.
10
Cyclovirobuxine D, a cardiovascular drug from traditional Chinese medicine, alleviates inflammatory and neuropathic pain mainly inhibition of voltage-gated Ca3.2 channels.环维黄杨星D,一种来自中药的心血管药物,主要通过抑制电压门控Ca3.2通道来减轻炎症性疼痛和神经性疼痛。
Front Pharmacol. 2022 Dec 21;13:1081697. doi: 10.3389/fphar.2022.1081697. eCollection 2022.